Jump to main content
Jump to site search

Issue 19, 2017
Previous Article Next Article

Solubility improvement of epalrestat by layered structure formation via cocrystallization

Author affiliations

Abstract

Epalrestat, a drug for diabetic neuropathy, was able to form a cocrystal with a pharmaceutically acceptable coformer of caffeine. The cocrystal was characterized using powder X-ray diffraction and infrared spectroscopy, and the structure was determined using single crystal structure analysis. Pharmaceutically relevant physicochemical properties such as solubility, dissolution rate, and physical stability were evaluated. The cocrystal exhibited higher solubility and faster dissolution than the parent drug material. This improvement corresponded to the formation of a layered structure in the cocrystal, wherein a chain consisting of epalrestat molecules is sandwiched between caffeine molecules. The cocrystal also exhibited physical stability during a slurry experiment in most organic solvents, except in dimethylformamide (DMF) and dimethyl sulfoxide (DMSO) solvents. In these solvents, the cocrystals underwent disproportionation into caffeine and epalrestat solvates (DMF and DMSO), and the crystal structures of epalerstat DMF and DMSO solvates are also reported in this study.

Graphical abstract: Solubility improvement of epalrestat by layered structure formation via cocrystallization

Back to tab navigation

Supplementary files

Publication details

The article was received on 10 Feb 2017, accepted on 30 Mar 2017 and first published on 30 Mar 2017


Article type: Paper
DOI: 10.1039/C7CE00284J
Citation: CrystEngComm, 2017,19, 2614-2622
  •   Request permissions

    Solubility improvement of epalrestat by layered structure formation via cocrystallization

    O. D. Putra, D. Umeda, Y. P. Nugraha, T. Furuishi, H. Nagase, K. Fukuzawa, H. Uekusa and E. Yonemochi, CrystEngComm, 2017, 19, 2614
    DOI: 10.1039/C7CE00284J

Search articles by author

Spotlight

Advertisements